Status:
UNKNOWN
The Real World Study of Apatinib for Gastric Cancer Treatment in Henan Province
Lead Sponsor:
Henan Cancer Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .
Eligibility Criteria
Inclusion
- Male or female patients .
- Confirmed by Pathology or histology of Gastric cancer.
- Patients should be voluntary to the trial and provide with signed informed consent.
- The researchers believe patients can benefit from the study.
Exclusion
- Patients with a known history of allergic reactions and/or hypersensitivity attributed to apatinib or its accessories.
- Pregnant or lactating women.
- Patients with Apatinib contraindications.
- Patients of doctors considered unsuitable for the trial.
Key Trial Info
Start Date :
January 30 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03478943
Start Date
January 30 2016
End Date
December 1 2020
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henan Cancer Hospital
Zhengzhou, Henan, China, 450008